| CAS ID: | 2609-46-3 |
| Molecular Formula: | C6H8ClN7O |
| Molecular Weight: | 229.6 g/mol |
| Monoisotopic Mass: | 229.0479 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | BERKAMIL | AMILORIDE HYDROCHLORIDE | Amiloride | AMILAMONT | AMIPRAMIDINE | Hydro-Ride | AMORIDE | MIDAMOR | Midamor | AMILOSPARE 5 |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 19633071 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,human,mice | Fibrosis Disease | Cystic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Reference Record 2
| PubMed ID | 25371970 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,rabbit | Fibrosis Disease | Scar |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT00274391 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | January 10, 2006 | Last Verified | January 10, 2006 |
| Sponsor | University of North Carolina | ||
Trial Record 2
| ClinicalTrial ID | NCT00547053 | Disease | Cystic fibrosis |
| Phase | Phase 1 | Status | Completed |
| First Received | October 19, 2007 | Last Verified | May 13, 2011 |
| Sponsor | Boston Children’s Hospital | ||
Trial Record 3
| ClinicalTrial ID | NCT00004705 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | February 25, 2000 | Last Verified | March 25, 2015 |
| Sponsor | FDA Office of Orphan Products Development | ||